Proton Pump Inhibitor (PPI) Therapy

DRUG3 trials

Sponsors

LCMC Health, Tanta University, University of Mons

Conditions

Gastroesophageal RefluxHELICOBACTER PYLORI INFECTIONSHelicobacter InfectionHelicobacter Pylori Gastrointestinal Tract InfectionHelicobacter Pylori Infected PatientsLaryngopharyngeal Reflux DiseaseNon-erosive Reflux Disease

Phase 2

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

RecruitingNCT07293910

Tanta UniversityHelicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection, Helicobacter Pylori Infected Patients +1

Start: 2026-02-15End: 2026-12-20Target: 66Updated: 2026-02-13

Phase 4

Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease

Not yet recruitingNCT07611162

University of MonsLaryngopharyngeal Reflux Disease

Start: 2026-05-01End: 2030-05-01Target: 800Updated: 2026-05-28

Unknown Phase

Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection

TerminatedNCT02788591

LCMC HealthGastroesophageal Reflux, Non-erosive Reflux Disease

Start: 2015-08-31End: 2021-06-30Updated: 2022-02-09